Myoscience Focused Cold Therapy Device Receives FDA Clearance

Myoscience in Redwood City, Calif., a medical device company, announced that the newest generation of its patented device technology has received FDA clearance for the treatment of pain.   

Advertisement

Focused Cold Therapy — the patented technology — delivers cold to targeted nerves. The cold induces a hibernating state and achieves an immediate result.

The hand-held device allows for treatment of pain without systemic side effects or addictive potential.

More Articles on Pain Management:

SPR Therapeutics Raise $5M For Commercializing Pain Therapies
Study: Joint Disorders, Back Pain Among Top Reasons People Visit Physicians
Study: Vitamin D May Not Prevent Osteoarthritis

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.